FDA, FTC Warn Companies Marketing Supplements as Opioid ...
CSPI Newsroom-Jan 24, 2018
The U.S. Food and Drug Administration and the Federal Trade Commission today warned marketers and distributors of 12 dietary supplements marketed as opioid withdrawal aids that they can no longer market these products with drug treatment claims—a big step toward getting these harmful products off the market.
No comments:
Post a Comment